Global Predictive Diagnostics Market Analysis 2013-2018: Increasing Incidence and Prevalence of CDDs is a Major Growth Driver
DUBLIN, Ireland, December 6, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/7l88g3/predictive) has announced the addition of the "Predictive Diagnostics - Global Strategic Business Report" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
This report analyzes the worldwide markets for Predictive Diagnostics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets.
The report profiles 58 companies including many key and niche players such as:
- Abbott Molecular
- Almac Group Ltd.
- BioGenex
- Covance, Inc.
- Dako Denmark A/S
- Epistem Plc
- F. Hoffmann-La Roche Ltd.
- Genomic Health, Inc.
- MDxHEALTH, Inc.
- Myriad Genetics, Inc.
- Precision Therapeutics, Inc.
- Prometheus Laboratories
- QIAGEN N.V.
Key Topics Covered:
I. Introduction, Methodology & Product Definitions
II. Executive Summary
1. Industry Overview
2. Major Market Trends, Drivers & Issues
3. Product Overview
4. Recent Industry Activity
5. Focus On Select Players
6. Global Market Perspective
III. Market
1. The United States
2. Canada
3. Japan
4. Europe
5. Rest Of World
IV. Competitive Landscape
Total Companies Profiled: 58 (including Divisions/Subsidiaries - 61)
- The United States (31)
- Canada (2)
- Europe (19)
- - Germany (4)
- - The United Kingdom (7)
- - Spain (1)
- - Rest of Europe (7)
- Asia-Pacific (Excluding Japan) (7)
- Middle East (2)
For more information visit http://www.researchandmarkets.com/research/7l88g3/predictive
Research and Markets
Laura Wood, Senior Manager.
[email protected]
U.S. Fax: +1-646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Diagnostics
SOURCE Research and Markets
Share this article